Table 2 Comparison of demographic, clinical and cognitive parameters between NMDAab negative and NMDAab positive PD patients
From: No association between Parkinson disease and autoantibodies against NMDA-type glutamate receptors
Metric between nmda negative and nmda positive PD patients | Value | Test | P-value |
|---|---|---|---|
Sample age | mean/sd | t-test | 0.655 |
Age PD onset | mean/sd | t-test | 0.316 |
PD duration | mean/sd | t-test | 0.401 |
UPDRS III | median/mad | MWU | 0.723 |
MMSE | median/mad | MWU | 0.808 |
PANDA | median/mad | MWU | 0.174 |
Wechsler Memory Scale digit span reverse, number of correct numerical series | median/mad | MWU | 0.259 |
Modified Card Sorting Test, Categories completed | median/mad | MWU | 0.325 |
Stroop Test reading colours (s) | median/mad | MWU | 0.190 |
Stroop Test naming colours (s) | median/mad | MWU | 0.390 |
Stroop Test interference (s) | median/mad | MWU | 0.589 |
CERAD Trail Making Test A, time to complete (s) | median/mad | MWU | 0.075 |
CERAD Trail Making Test B, time to complete (s) | median/mad | MWU | 0.167 |
CERAD word list memory test, sum score of 3 trails, immediate recall (range 0–30) | median/mad | MWU | 0.163 |
CERAD word list, delayed free recall (range 0–10) | median/mad | MWU | 0.308 |
Performance Evaluation System for Seniors (LPS 50+) subtest spatial abilities, sum of correct items | median/mad | MWU | 0.070 |